Annual Report FY26 and 11th AGM notice sent to shareholders

Related Party TransactionsResults View source PDF Explain this filing

LASA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

—Next day

—

prior close

₹5.89

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%—

Pharmaceuticals peers, median of 175sector+0.1%—

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—-0.1—+0.2—

Next day

—+0.3—+0.1—

—+1.6—+1.0—

—+0.1—-0.0—

—+0.3—+0.1—

—-1.2—-0.5—

—-0.5—-1.0—

15d

—-2.2—-4.5—

—-6.6—-7.3—

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 175Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

LASA Supergenerics has circulated its Annual Report for FY ended March 31, 2026 and Notice of the 11th AGM to be held on September 30, 2026 at 09:30 AM via video conferencing. E-voting cut-off date is September 23, 2026. AGM resolutions include adoption of accounts, appointment of secretarial auditor Mr. Shivam Sharma for 5 years, appointment of Mr. Janardan Savala as Executive Director for 5 years, approval of donations up to Rs 2 crore annually including to Dr Omkar Herlekar Foundation, managerial remuneration up to Rs 3 crore in case of inadequate profits, and enhanced borrowing powers.

Likely market impact

Shareholders should note AGM on Sep 30 and e-voting cut-off on Sep 23. Key items include donations to Chairman-related foundation and higher borrowing limits.